Recommended Secondary Reagents: F(ab')2 rabbit anti-mouse IgG HRP
Immunohistochemistry: Recommended Positive Control Tissue: Brain.
Applications:
Immunohistochemistry (frozen)
Immunoprecipitation
Western Blot
Note: Applications are based on unconjugated antibody.
Recommended Secondary Reagents: F(ab')2 rabbit anti-mouse IgG HRP
Immunohistochemistry: Recommended Positive Control Tissue: Brain.
Applications:
Immunohistochemistry (frozen)
Immunoprecipitation
Western Blot
Note: Applications are based on unconjugated antibody.
Shipping & Handling
Shipped In
Cold Packs
Safety & Storage
Storage Temperature
-20°C
Safety Statement
For laboratory research and development purposes only.
Regulatory & Compliance
Specifications
CLASS
Monoclonal Antibodies
SUBCLASS
Disease Markers
APPLICATION
IHC IP WB
CLONE NUMBER
HDB4E10
*USAGE / SAFETY STATEMENT
For laboratory research and development purposes only.
PURITY
Purified IgG.
PHYSICAL FORM
Supplied as a liquid in PBS, pH 7.2. Labeled with Biotin.
GRADE
Purified
ANTIBODY TYPE
Mab
HOST SPECIES
human
ISOTYPE
IgG1
CROSS REACTIVITY
Hu Mo Rb
IMMUNOGEN
Recombinant protein corresponding to amino acids 1844 - 2131 of huntingtin.
SPECIFIC ACTIVITY
Reacts with an epitope corresponding to the HDB region (amino acids 1844-2131) of the huntingtin protein. Clone HDB4E10 detects a 350kD band on western blots but also detects smaller degradation products of huntingtin. The combined use of clone HDB4E10, HDC8A4 and HDA3E10 demonstrate that huntingtin is enriched in neuronal cells in the brain. Species Crossreactivity: human, rabbit, mouse
SWISS PROT#
P42858
COMMODITY CODE
30021010
HOST
mouse
Questions & Answers (0)
Citations (0)
Shipping & Handling
Shipped In
Cold Packs
Safety & Storage
Storage Temperature
-20°C
Safety Statement
For laboratory research and development purposes only.
Regulatory & Compliance
We’re currently in BETA - Interested in joining? Let us know and we’ll get you set up with early access.
We’re currently in BETA - Interested in joining? Let us know and we’ll get you set up with early access.